secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXAGEN INC. (XGN)
CIK:        0001274737
Form:       8-K
Filed at:   2025-07-29T23:59:59+00:00
Accession:  0001274737-25-000061
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exagen Q2 revenue $17.2M (+14% YoY); net loss widens to $4.4M; FY guidance $65-70M
--------------------------------------------------------------------------------

- Revenue $17.2M, 14% YoY growth; AVISE CTD test volume +7% YoY, +14% QoQ; gross margin 60.4%.
- Net loss $4.4M vs $3.0M in Q2 2024; operating loss $2.6M, roughly flat; adjusted EBITDA -$1.7M.
- Cash $30.0M after $20.2M public offering and new credit facility; ASP $428, up $27 YoY.
- FY 2025 revenue guidance $65M-$70M; expects positive adjusted EBITDA in Q4 at high end.
- Appointed Dr. Michael Mahler as CSO; added Chas McKhann to board of directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1274737/000127473725000061/0001274737-25-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1274737/000127473725000061/exdx-20250729.htm
  HTML page:      https://secwatch.observer/filing/0001274737-25-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer